Scientists Uncover Connection Between Metabolic Processes, Immunity, and Skeletal Function

Fat inside bones is turning out to be far more dangerous than anyone expected.

A new study published in Bone Research challenges the long-held belief that higher body weight protects bone health. Instead, researchers show that obesity can actively weaken bones—not just through excess weight, but by reshaping the immune environment inside bone marrow.

At the center of this discovery is bone marrow adipose tissue, a specialized fat depot within bones. In obese mouse models, scientists observed a rapid expansion of this fat, which began releasing signaling molecules like MCP-1. This triggered an increase in immune cells expressing PD-L1, a key regulator in the PD-1/PD-L1 pathway. While this pathway is best known for suppressing immune responses, the study found it also plays a surprising role in bone breakdown.

These PD-L1-positive immune cells not only dampened T-cell activity—creating an immunosuppressive environment—but also directly promoted the formation of osteoclasts, the cells responsible for bone resorption. As osteoclast activity increased, bone density declined, affecting both trabecular and cortical bone structure.

Crucially, when researchers blocked the PD-1/PD-L1 interaction, osteoclast formation dropped significantly, suggesting a potential therapeutic target. Even more striking, genetically modified mice lacking bone marrow fat showed fewer immune disruptions and improved bone structure, despite being obese.

This research reframes bone marrow fat as an active driver of disease rather than a passive bystander. It also helps explain why obesity is linked not only to weaker bones but also to broader immune dysfunction, including poorer vaccine responses and higher infection risk.

The implications are far-reaching. Drugs targeting immune checkpoints—already used in cancer therapy—could one day be repurposed to treat obesity-related bone loss.

By uncovering this hidden link between metabolism, immunity, and skeletal health, the study opens the door to more integrated approaches in tackling chronic disease.

REFERENCE: Costa, S. N., et al. (2026). Expansion of bone marrow adipocytes in obese mice leads to PD-L1-driven bone marrow immunosuppression and osteoclastogenesis. Bone Research. DOI: 10.1038/s41413-026-00509-5. https://www.nature.com/articles/s41413-026-00509-5